scispace - formally typeset
Journal ArticleDOI

Clinical outcomes of Ex Vivo liver resection and liver autotransplantation for hepatic alveolar echinococcosis

TLDR
It could be the most effective method to cure intractable hepatic alveolar echinococcosis if correct handling in operation and proper prevention of complications are performed and the long-term outcomes are still needed to be confirmed in longer follow-up.
Abstract
The effectiveness of liver autotransplantation for patients with partial hepatic alveolar echinococcosis was analyzed. We retrospectively studied 6 patients with hepatic alveolar echinococcosis who underwent liver autotransplantation in our hospital from 2008 to 2010. We also summarized the surgical indications of liver autotransplantation for hepatic alveolar echinococcosis and our experience in the management of postoperative complications of liver autotransplantation. Of 6 patients, 5 achieved good curative results, and one died of multiple organ failure caused by portal vein thrombosis. Main complications included postoperative bleeding, bile leak and small-for-size liver graft syndrome. Liver autotransplantation offers a new approach to cure hepatic alveolar echinococcosis with non-resectable lesions. It could be the most effective method to cure intractable hepatic alveolar echinococcosis if correct handling in operation and proper prevention of complications are performed. But the long-term outcomes are still needed to be confirmed in longer follow-up.

read more

Citations
More filters
Journal ArticleDOI

Current interventional strategy for the treatment of hepatic alveolar echinococcosis

TL;DR: This article reviews the current respective indications of surgical, percutaneous and perendoscopic interventions in AE and proposes an integrative therapeutic strategy that is best adapted to alleviating the biliary complications that are common and life-threatening in AE patients.
Journal ArticleDOI

Novel techniques and preliminary results of ex vivo liver resection and autotransplantation for end-stage hepatic alveolar echinococcosis: A study of 31 cases.

TL;DR: The manipulation details are discussed and reasonable indications for this promising technique are proposed, which requires neither an organ donor nor any postoperative immunosuppressant and relies on meticulous preoperative assessments and precise surgical manipulation.
Journal ArticleDOI

Ex vivo liver resection followed by autotransplantation to a patient with advanced alveolar echinococcosis with a replacement of the retrohepatic inferior vena cava using autogenous vein grafting: a case report and literature review.

TL;DR: Ex vivo liver resection followed by autotransplantation with a replacement of the retrohepatic IVC using autogenous vein grafting might be a useful surgical practice for advanced AE.
Journal ArticleDOI

The choose of different surgical therapies of hepatic alveolar echinococcosis: A single-center retrospective case-control study.

TL;DR: It is believed in that all stages of hepatic alveolar echinococcosis should take active surgical interventions, and radical hepatic resection should be considered as the first-choice treatment for early stage of alveolars echinOCoccosis, while palliative surgery is still helpful to relieve symptoms and improve the life quality for advanced patients.
References
More filters
Journal ArticleDOI

Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report.

TL;DR: This unique experience indicates that LT is feasible for life-threatening AE, and specific management is needed to optimize the results: earlier decision for LT in incurable symptomatic biliary AE, pre- and post-LT BZM therapy, meticulous pre-LT evaluation to identify extrahepatic extension, and an immunosuppressive regimen kept to a minimum.
Journal ArticleDOI

Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis

TL;DR: Alveolar echinococcosis is a rare disorder, which makes a comparison of different treatment modalities within a clinical trial difficult to perform, and data prospectively recorded over a period of 25 years were used to evaluate three therapeutic strategies: benzimidazole therapy alone, complete ‘curative’ resection followed by 2 years of adjuvant benzimdazole treatment.
Journal ArticleDOI

Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study†‡§

TL;DR: Using anti‐rEm18 or anti‐Em2plus Ab levels and the delayed acquisition of FDG‐PET images can improve the functional assessment of disease activity and the potential recurrence of disease should not be regarded as a contraindication to LT when AE is considered to be lethal in the short term.
Journal ArticleDOI

Ex situ resection techniques and liver autotransplantation: last resource for otherwise unresectable malignancy.

TL;DR: These two cases are the paradigm of the possibility of performing extreme salvage procedures after the failure of more conventional treatments, allowing improvement in survival and quality of life in a controversial clinical scenario.
Journal ArticleDOI

Initial clinical results of orthotopic liver transplantation for hepatic alveolar echinococcosis.

TL;DR: This study suggests that OLT is feasible for incurable AE of the liver and that this procedure ensures a good clinical outcome.
Related Papers (5)